Tingting Zhao, Xuening Li, Yanwei Chen, Jie Du, Xiaodong Chen, Dalong Wang, . . . Jingjing Wu. (2022). Risk assessment and molecular mechanism study of drug-drug interactions between rivaroxaban and tyrosine kinase inhibitors mediated by CYP2J2/3A4 and BCRP/P-gp. Frontiers Media S.A..
Chicago Style (17th ed.) CitationTingting Zhao, et al. Risk Assessment and Molecular Mechanism Study of Drug-drug Interactions Between Rivaroxaban and Tyrosine Kinase Inhibitors Mediated by CYP2J2/3A4 and BCRP/P-gp. Frontiers Media S.A., 2022.
MLA (9th ed.) CitationTingting Zhao, et al. Risk Assessment and Molecular Mechanism Study of Drug-drug Interactions Between Rivaroxaban and Tyrosine Kinase Inhibitors Mediated by CYP2J2/3A4 and BCRP/P-gp. Frontiers Media S.A., 2022.
Warning: These citations may not always be 100% accurate.